Literature DB >> 9877260

An increase of circulating leptin in patients with liver cirrhosis.

H Shimizu1, S Kakizaki, T Tsuchiya, T Nagamine, H Takagi, H Takayama, I Kobayashi, M Mori.   

Abstract

OBJECTIVE: Leptin, the ob gene product, is an anorexigenic peptide secreted from adipose tissue. However, the mechanism of leptin clearance/degradation has not been well determined in humans. The present study was undertaken to examine a possible involvement of liver in determining circulating leptin concentrations in humans.
SUBJECTS: In the present study 58 healthy control subjects and 68 patients with liver cirrhosis (LC) without any renal dysfunction were randomly included.
METHOD: The serum immunoreactive leptin (IRL) concentrations relative to the body mass index (BMI) were determined. Serum IRL and estradiol (E2) concentrations were assayed by radioimmunoassay (RIA).
RESULTS: The correlations between the BMI and circulating IRL concentrations were all significant in male healthy controls (M-C), male patients with LC (M-LC), female healthy controls (F-C) and female patients with LC (F-LC). Circulating IRL concentrations were significantly higher than control in F-LC but not M-LC groups. The ratio of circulating IRL concentrations to the BMI was significantly higher in the M-LC group than in the M-C group and also significantly higher in the F-LC group than in the F-C group. The correlation between the IRL/BMI ratio and serum total bilirubin concentrations was significant (r = 0.417, P < 0.05) in the M-LC group, but not in the F-LC group. There was no significant correlation of the IRL/BMI ratio to serum E2 or albumin concentrations in either M-LC or F-LC groups.
CONCLUSION: The present data demonstrated that the rate of increase in circulating IRL concentrations with the BMI was higher in LC patients of both genders. Liver may play a role in determining circulating leptin levels.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9877260     DOI: 10.1038/sj.ijo.0800768

Source DB:  PubMed          Journal:  Int J Obes Relat Metab Disord


  6 in total

1.  Leptin levels in the differential diagnosis between benign and malignant ascites.

Authors:  Mehmet Buyukberber; Mehmet Koruk; M-Cemil Savas; Murat-T Gulsen; Yavuz Pehlivan; Rukiye Deveci; Alper Sevinc; Serdar Gergerlioglu
Journal:  World J Gastroenterol       Date:  2007-01-21       Impact factor: 5.742

2.  Alterations in serum leptin in chronic liver disease.

Authors:  Ziv Ben-Ari; Zahava Schafer; Jaqueline Sulkes; Varda Manhaim; Ran Tur-Kaspa; Menahem Fainaru
Journal:  Dig Dis Sci       Date:  2002-01       Impact factor: 3.199

3.  Fatigue is associated with high circulating leptin levels in chronic hepatitis C.

Authors:  T Piche; E Gelsi; S M Schneider; X Hébuterne; J Giudicelli; B Ferrua; C Laffont; S Benzaken; P Hastier; M L Montoya; F Longo; P Rampal; A Tran
Journal:  Gut       Date:  2002-09       Impact factor: 23.059

4.  High ascitic fluid leptin levels in patients with decompensated liver cirrhosis and sterile ascites: relationship with TNF-alpha levels.

Authors:  Edoardo Giannini; Paola Romagnoli; Gian Luca Tenconi; Federica Botta; Federica Malfatti; Bruno Chiarbonello; Mario Mamone; Tommaso Barreca; Roberto Testa
Journal:  Dig Dis Sci       Date:  2004-02       Impact factor: 3.199

5.  The role of liver in leptin metabolism in experimental nephrotic syndrome.

Authors:  Dawoud Fakhry Habib; Abdelgawad Ali Fahmi; Naglaa Mohamed Kholousy; Ahmed Ibrahim Amin; Mostafa Shalaby; Mohamed Mahmoud Ahmed; Asem Metwally Abo Shanab
Journal:  EXCLI J       Date:  2011-12-19       Impact factor: 4.068

6.  Potential involvement of leptin in carcinogenesis of hepatocellular carcinoma.

Authors:  Xiu-Jie Wang; Shu-Lan Yuan; Qing Lu; Yan-Rong Lu; Jie Zhang; Yan Liu; Wen-Dong Wang
Journal:  World J Gastroenterol       Date:  2004-09-01       Impact factor: 5.742

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.